Neuromyelitis optica spectrum disorders: long-term safety and efficacy of rituximab in Caucasian patients

Radaelli M.; Moiola L.; Sangalli F.; Esposito F.; Barcella V.; Ferre L.; Rodegher M.; Colombo B.; Fazio R.; Martinelli V.; Comi G.

首页> 外文期刊>Multiple sclerosis: clinical and laboratory research >Neuromyelitis optica spectrum disorders: long-term safety and efficacy of rituximab in Caucasian patients

【24h】

Neuromyelitis optica spectrum disorders: long-term safety and efficacy of rituximab in Caucasian patients

机译：视神经脊髓炎频谱疾病：利妥昔单抗在白种人患者中的长期安全性和有效性

获取原文

获取原文并翻译 | 示例

获取外文期刊封面封底 >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

Objective: To assess the long-term benefit-risk profile of repeated courses of rituximab in Caucasian patients affected by neuromyelitis optica (NMO) and related disorders, in everyday clinical practice.

机译：目的：在日常临床实践中，评估利妥昔单抗重复疗程对视神经脊髓炎（NMO）和相关疾病影响的白种人患者的长期获益风险。

著录项

来源
《Multiple sclerosis: clinical and laboratory research》 |2016年第4期|共9页
作者
Radaelli M.; Moiola L.; Sangalli F.; Esposito F.; Barcella V.; Ferre L.; Rodegher M.; Colombo B.; Fazio R.; Martinelli V.; Comi G.;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类神经病学与精神病学;
关键词
Adverse effects; antibody levels; disability; efficacy; infections; neuromyelitis optica; optic neuritis; recurrent transverse myelitis; risk profile; rituximab; safety;

机译：不良反应;抗体水平;残疾;功效;感染;视神经脊髓炎;视神经炎;复发性横贯性脊髓炎;风险状况;利妥昔单抗;安全性;

相似文献

外文文献
中文文献
专利

1. Neuromyelitis optica spectrum disorders: long-term safety and efficacy of rituximab in Caucasian patients [J] . Radaelli M., Moiola L., Sangalli F., Multiple sclerosis: clinical and laboratory research . 2016,第4期

机译：视神经脊髓炎频谱疾病：利妥昔单抗在白种人患者中的长期安全性和有效性
2. Neuromyelitis optica spectrum disorders: long-term safety and efficacy of rituximab in Caucasian patients [J] . Radaelli M., Moiola L., Sangalli F., Multiple sclerosis: clinical and laboratory research . 2016,第4期

机译：神经髓炎OPTICA谱紊乱：高加索患者中RITUXIMAB的长期安全性和功效
3. Long-term tolerability, safety and efficacy of rituximab in neuromyelitis optica spectrum disorder: a prospective study [J] . Shaygannejad V., Fayyazi E., Badihian S., Journal of neurology . 2019,第3期

机译：Rituximab在神经肌炎OPTICA谱系中的长期耐受性，安全性和有效性：一项潜在研究
4. Oligoelonal IgM bands in cerebrospinal fluid of neuromyelitis optioa spectrum disorders [C] . Magraner M., Bosca I., Simo-Castello M., European Congress of Immunology . 2009

机译：神经肌炎OPTIOA谱紊乱脑脊髓液中的寡偶联IgM带
5. Safety and Efficacy of the Immunomodulatory Drug (IMiD) Lenalidomide in Patients with Lymphoma: Development of RU051417I - Phase I/II Open-Label Study of R-ICE (Rituximab-Ifosfamide-Carboplatin-Etoposide) with Lenalidomide [R2-ICE] in Patients with First-Relapse/Primary Refractory Diffuse Large B-Cell Lymphoma (DLBCL). [D] . Kasi, Pashtoon Murtaza. 2018

机译：免疫调节药物来那度胺在淋巴瘤患者中的安全性和有效性：RU051417I-R-ICE（利妥昔单抗-异环磷酰胺-卡铂-依托泊苷）与来那度胺[R2-ICE]的I / II期开放标签研究的进展初次复发/原发性难治性弥漫性大B细胞淋巴瘤（DLBCL）。
6. Efficacy and safety of rituximab in patients with refractory neuromyelitis optica spectrum disorders: A prospective observation in Iranian cases [O] . Maral Seyed Ahadi, Abdorreza Naser Moghadasi, Nasrin Asgari, 2020

机译：利妥昔单抗在难治性神经脊髓炎视神经频谱疾病患者中的疗效和安全性：伊朗病例的前瞻性观察
7. Efficacy and Safety of Rituximab Therapy in Neuromyelitis Optica Spectrum Disorders [O] . Valentina Damato, Amelia Evoli, Raffaele Iorio 2016

机译：利妥昔单抗治疗神经髓炎OPTICA谱紊乱的疗效和安全性

Neuromyelitis optica spectrum disorders: long-term safety and efficacy of rituximab in Caucasian patients

摘要

著录项

相似文献

相关主题

期刊订阅